Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis

Adoptive cellular therapy (ACT) with the Th17 subset of CD4(+) T cells can cure established melanoma in preclinical models and holds promise for treating human cancer. However, little is known about the growth factors necessary for optimal engraftment and anti-tumor activity of Th17 cells. Due to th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Immunol Immunother
Päätekijät: Neitzke, Daniel J., Bowers, Jacob S., Andrijauskaite, Kristina, O’Connell, Nathaniel S., Garrett-Mayer, Elizabeth, Wrangle, John, Li, Zihai, Paulos, Chrystal M., Cole, David J., Rubinstein, Mark P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2017
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5679708/
https://ncbi.nlm.nih.gov/pubmed/28280853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-017-1965-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia